Published in Microsc Microanal on January 05, 2012
Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation. Circ Res (2013) 1.61
Flow patterns regulate hyperglycemia-induced subendothelial matrix remodeling during early atherogenesis. Atherosclerosis (2013) 0.82
Introduction: Extracellular matrix and cardiovascular remodeling-using microscopy to delineate mechanisms. Microsc Microanal (2012) 0.75
Microbiota of Chronic Diabetic Wounds: Ecology, Impact, and Potential for Innovative Treatment Strategies. Front Microbiol (2017) 0.75
Non-invasively estimated end-systolic elastance in patients with resistant hypertension and type 2 diabetes mellitus. Heart Vessels (2013) 0.75
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med (2005) 27.77
Cellular mechanisms of insulin resistance. J Clin Invest (2000) 12.61
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
The myofibroblast: one function, multiple origins. Am J Pathol (2007) 8.64
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A (2002) 6.98
The myofibroblast in wound healing and fibrocontractive diseases. J Pathol (2003) 6.16
PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci (2001) 6.11
Formation and function of the myofibroblast during tissue repair. J Invest Dermatol (2007) 6.11
Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation (2006) 5.31
Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) (2005) 4.96
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology (2005) 4.86
New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol (1972) 4.86
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation (2007) 4.62
Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care (2003) 4.50
Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol (2001) 4.39
Cellular and molecular basis of wound healing in diabetes. J Clin Invest (2007) 4.22
Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther (2009) 4.21
Advanced protein glycosylation in diabetes and aging. Annu Rev Med (1995) 4.13
Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care (2001) 4.09
Tissue repair, contraction, and the myofibroblast. Wound Repair Regen (2005) 3.70
The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol (2005) 3.47
How does proteinuria cause progressive renal damage? J Am Soc Nephrol (2006) 3.46
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation (2003) 3.30
Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res (2006) 3.27
Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation (2002) 3.20
Myocardial cell death in human diabetes. Circ Res (2000) 3.12
Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation (2007) 3.12
PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol (1990) 3.04
Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab (2008) 3.00
Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am J Physiol Heart Circ Physiol (2007) 2.97
Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res (2010) 2.89
The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int (1999) 2.87
Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol (2003) 2.85
The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care (2004) 2.79
A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res (2003) 2.69
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol (2002) 2.65
Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest (1968) 2.60
Protein glycation, diabetes, and aging. Recent Prog Horm Res (2001) 2.51
Diabetic cardiomyopathy, causes and effects. Rev Endocr Metab Disord (2010) 2.47
Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens (2003) 2.45
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat Med (2000) 2.44
Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med (2008) 2.42
Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int (2008) 2.34
Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol Biol Cell (2004) 2.29
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol (2010) 2.18
Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation (2002) 2.18
The collagen network of the heart. Lab Invest (1979) 2.08
A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation (1990) 2.05
Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation (2001) 1.92
Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med (2004) 1.89
Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3. Hypertension (2009) 1.85
Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum (2002) 1.85
Type 1 diabetes, hyperglycaemia, and the heart. Lancet (2008) 1.83
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry (1991) 1.75
Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol (2005) 1.66
Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes (1989) 1.64
Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes (1983) 1.64
Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol (2004) 1.58
Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes (2003) 1.56
Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification. Diabetes (2006) 1.54
Oxidation of glycated proteins: age-dependent accumulation of N epsilon-(carboxymethyl)lysine in lens proteins. Biochemistry (1989) 1.53
Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease. Hepatology (2005) 1.48
Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product-dependent increase in imidazolium cross-links in human lens proteins. J Biol Chem (1998) 1.45
The role of AGEs in aging: causation or correlation. Exp Gerontol (2001) 1.42
RAGE in inflammation: a new therapeutic target? Curr Opin Investig Drugs (2006) 1.40
Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol (2000) 1.36
Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation (1996) 1.35
Diabetic cardiomyopathy. the importance of being earliest. J Am Coll Cardiol (2003) 1.35
Left ventricular function in diabetes mellitus. I: Methodology, and prevalence and spectrum of abnormalities. Br Heart J (1981) 1.33
Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia (2005) 1.33
Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes. J Biol Chem (2005) 1.33
Increased congestive heart failure after myocardial infarction of modest extent in patients with diabetes mellitus. Am Heart J (1984) 1.33
Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell Signal (2008) 1.32
Collagen and the myocardium: fibrillar structure, biosynthesis and degradation in relation to hypertrophy and its regression. Mol Cell Biochem (1990) 1.32
Type VI collagen induces cardiac myofibroblast differentiation: implications for postinfarction remodeling. Am J Physiol Heart Circ Physiol (2005) 1.31
Identification and quantification of major maillard cross-links in human serum albumin and lens protein. Evidence for glucosepane as the dominant compound. J Biol Chem (2002) 1.30
In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. J Biol Chem (1997) 1.29
Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol (1997) 1.21
Galpha12/13-mediated up-regulation of TRPC6 negatively regulates endothelin-1-induced cardiac myofibroblast formation and collagen synthesis through nuclear factor of activated T cells activation. J Biol Chem (2007) 1.21
The effect of streptozotocin-induced diabetes in rats on cardiac contractile proteins. Circ Res (1981) 1.20
Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail (2007) 1.20
Excess mortality and its relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes. Diabetes Care (1996) 1.20
Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol (1993) 1.19
Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet Med (2006) 1.16
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein. Diabetes (1985) 1.16
Collagen turnover and its regulation in the normal and hypertrophying heart. Eur Heart J (1995) 1.15
Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. Am J Physiol Heart Circ Physiol (2009) 1.13
Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci U S A (1996) 1.13
Diabetic cardiomyopathy: the preclinical phase. Br Med J (1977) 1.07
Attenuation of endocrine-exocrine pancreatic communication in type 2 diabetes: pancreatic extracellular matrix ultrastructural abnormalities. J Cardiometab Syndr (2008) 1.06
Left ventricular function in diabetes mellitus. II: Relation between clinical features and left ventricular function. Br Heart J (1981) 1.05
High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J Cell Biochem (2006) 1.05
Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy. Am J Physiol Heart Circ Physiol (2002) 1.03
Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab (2000) 1.03
Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem Biophys Res Commun (1996) 1.03
Myocardial infarct size and mortality in patients with non-insulin-dependent diabetes mellitus. J Intern Med (1994) 1.03
Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res (2008) 3.94
Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol (2006) 3.22
The pros and cons of apoptosis assays for use in the study of cells, tissues, and organs. Microsc Microanal (2002) 1.23
Effects of collagen density on cardiac fibroblast behavior and gene expression. J Cell Physiol (2003) 1.01
Influence of the extracellular matrix on the regulation of cardiac fibroblast behavior by mechanical stretch. J Cell Physiol (2004) 1.00
Using gold nanorods to probe cell-induced collagen deformation. Nano Lett (2007) 1.00
Expression of Discoidin Domain Receptor 2 (DDR2) in the developing heart. Microsc Microanal (2005) 0.94
Effects of interleukin-18 on cardiac fibroblast function and gene expression. Cytokine (2010) 0.93
Interaction of human tRNA-dihydrouridine synthase-2 with interferon-induced protein kinase PKR. Nucleic Acids Res (2007) 0.92
Adaptive changes in cardiac fibroblast morphology and collagen organization as a result of mechanical environment. Cell Biochem Biophys (2008) 0.91
A gene expression classifier of node-positive colorectal cancer. Neoplasia (2009) 0.91
Temporal alterations in cardiac fibroblast function following induction of pressure overload. Cell Tissue Res (2010) 0.90
Essential role of PACT-mediated PKR activation in tunicamycin-induced apoptosis. J Mol Biol (2008) 0.89
Fractal and image analysis of morphological changes in the actin cytoskeleton of neonatal cardiac fibroblasts in response to mechanical stretch. Microsc Microanal (2007) 0.87
The effect of gold nanorods on cell-mediated collagen remodeling. Nano Lett (2008) 0.87
Regulation of tissue fibrosis by the biomechanical environment. Biomed Res Int (2013) 0.86
Integrin shedding as a mechanism of cellular adaptation during cardiac growth. Am J Physiol Heart Circ Physiol (2003) 0.86
Effects of mast cells on the behavior of isolated heart fibroblasts: modulation of collagen remodeling and gene expression. J Cell Physiol (2002) 0.85
Type II diabetes promotes a myofibroblast phenotype in cardiac fibroblasts. Life Sci (2013) 0.84
IGF-1 modulation of rat cardiac fibroblast behavior and gene expression is age-dependent. Cell Commun Adhes (2003) 0.82
Effects of interleukin-33 on cardiac fibroblast gene expression and activity. Cytokine (2012) 0.82
Age-dependent expression of collagen receptors and deformation of type I collagen substrates by rat cardiac fibroblasts. Microsc Microanal (2011) 0.81
Localized targeting of biomaterials following myocardial infarction: a foundation to build on. Trends Cardiovasc Med (2013) 0.80
Polyelectrolyte-coated gold nanorods and their interactions with type I collagen. Biomaterials (2009) 0.80
Mechanical loading promotes mast cell degranulation via RGD-integrin dependent pathways. J Biomech (2012) 0.79
Effects of platelet-derived growth factor-AA and -BB on embryonic cardiac development. Anat Rec A Discov Mol Cell Evol Biol (2003) 0.78
Direct quantification of gene expression using capillary electrophoresis with laser-induced fluorescence. Anal Biochem (2006) 0.78
High-aspect-ratio gold nanorods: their synthesis and application to image cell-induced strain fields in collagen films. Methods Mol Biol (2013) 0.76
Initial management of mass-casualty incidents due to firearms: improving survival. Bull Am Coll Surg (2013) 0.75